 - Concurrent anti-cancer therapy chemotherapy, hormonal therapy, radiation therapy other than that specified by the protocol, surgery, immunotherapy, biologic therapy including trastuzumab, lapatinib, bevacizumab, tyrosine kinase inhibitors other than sorafenib or tumor embolization 